Foley Hoag Advises Axogen on $200M Acquisition of BioCircuit Technologies
October 02, 2026
October 02, 2026
BOSTON, Massachusetts, Oct. 2 [Category: BizLaw/Legal] -- Foley Hoag, a law firm, posted the following news:
* * *
Foley Hoag Advises Axogen on $200M Acquisition of BioCircuit Technologies
*
Foley Hoag advised Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing surgical solutions for the restoration of peripheral nerve function, in its $200 million acquisition of BioCircuit Technologies, Inc., a privately held medical devic . . .
* * *
Foley Hoag Advises Axogen on $200M Acquisition of BioCircuit Technologies
*
Foley Hoag advised Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing surgical solutions for the restoration of peripheral nerve function, in its $200 million acquisition of BioCircuit Technologies, Inc., a privately held medical devic . . .